For many diseases whose treatment involves frequent delivery of injectable drugs (diabetes, Parkinson's, osteoporosis, etc.), using continuous infusion pumps often leads to better outcomes than multiple daily injections, resulting in healthier patients and lower healthcare costs. Existing pumps' limitations, however, inhibit their adoption. Our Evopump - a more comfortable, precise, therapeutically flexible, and lower cost pump - should significantly increase adoption, yielding better outcomes

2014
2014 Boston Gold Winner